Skip to content
Home - Clinical trials - Losec™ (omeprazole) - Ongoing Studies    
Losec™ (omeprazole) Ongoing studies
Study NumberStudy PhaseStart DateStudy Status
D9584L00002Phase III23-Jan-2004Completed
A double-blind, randomised, parallel-group, multicentre, Phase III study to compare the efficacy of omeprazole 20mg and 10mg od for the four-week treatment of non-erosive reflux disease (NERD) with that of placebo od and to investigate the safety.
D9584L00003Phase III28-Jan-2004Completed
A double-blind, randomised, parallel-group, multicentre, Phase III study to investigate the pharmacodynamic effect by assessment of the 24 hours intra-esophageal pH level, the efficacy and safety of omeprazole 10mg and 20mg od in patients with non-erosive reflux disease (NERD).
D9584C0004Phase IV6-Jan-1998Completed
Omeprazole versus anti-reflux surgery in the long-term management of peptic esophagitis – a 10 year follow-up study of patients previously studied for 5 years – A Nordic multicentre study


AstraZeneca websites
Search
Corporate Responsibility
Quick links - Products
Page tools
>
>
>
>